DESCRIPTION (provided by applicant): The product that will result from this STTR is ABH (2(S)-amino-6-boronohexanoic acid), a potent small molecule inhibitor of the enzyme arginase, for treating vasc ...STTR Phase I 2010 Department of Health and Human Services
| Corridor Pharmaceuticals, Inc.
2330 W JOPPA RD, STE 330
LUTHERVILLE, MD, 21093-4690
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|